Searched for
EMCURE IPO LISTING
Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block dealBC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block ...- Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue fr...
- Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust listingThe robust listing met expectations, reflecting the company's long-term potential. Analysts recommend that investors maintain their positio...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharma IPO GMP: Street anticipates a robust listing tomorrow. Will it trump expectations?Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...
- Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
- IPO Calendar: 1 IPO, 5 listings investors need to watch out for next weekAnalysts believe that despite a temporary lull, India's strong economic fundamentals and promising growth outlook create an ideal environme...
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscriptionEmcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO incl...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- IPO Calendar: Primary market gears up for another robust week as 3 companies look to raise Rs 2,700 crApart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, wh...
- Bain Capital-backed Emcure Pharma to float IPO on July 3Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer...
- Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listingsThe Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Bain Capital-backed Emcure Pharma files fresh IPO papers with SebiThose selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity m...
- Emcure Pharmaceuticals gets Sebi's go-ahead to float IPOAs part of the OFS, promoters — Satish Mehta will offload 20.30 lakh equity shares, Sunil Mehta will sell 2.5 lakh equity shares — and inve...
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.
- Emcure Pharmaceuticals files DRHP for IPOEmcure Pharmaceuticals today said it has filed a DRHP with the SEBI for launching an initial public offer to raise an estimated Rs 300 cror...
Load More
